Regulatory Systems Must Be Consistent across Agencies and Based on Actual Risk Washington, D.C. (June 20, 2017) – In comments submitted to the U.S. Depart of Agriculture (USDA) and U.S. Food and Drug Administration (FDA), the...
Washington, DC (June 19, 2017) – Today, the Biotechnology Innovation Organization (BIO) released a set of principles on workforce development, diversity, and inclusion (WDDI) for the biotechnology industry. Concurrent with the...
BIO appreciates this opportunity to provide comments to the Food and Drug Administration (FDA) on its request for comments on genome editing in plants.
BIO is pleased to submit these comments in response to the USDA Animal and Plant Health Inspection Service’s (APHIS’) request for public input on the proposed revisions to its biotechnology regulations in 7 CFR Part 340.
New report demonstrates the enormous financial and jobs impact from patent licensing of university research, known as tech transfer. Real-world examples of success from the University of California System and Stanford University...
Intellectual Property, Legislation • Toolkit • June 15, 2017
The Bayh-Dole Act benefits the U.S. economy, taxpayers, consumers and patients, but certain activists are trying to undermine the law. Some want to force the government to "march-in" by arbitrarily tying prescription drugs prices...
BIO announced that biotech industry veteran Vonnie Estes will receive the 4th annual Rosalind Franklin Award for Leadership in Industrial Biotechnology on Tuesday July 25, 2017, during a lunch plenary session of the 2017 BIO...
On behalf of the advanced and cellulosic biofuel industry and our respective companies and organizations, we are writing to ask for your support for the Consumer and Fuel Retailer Choice Act (S. 517), which is scheduled to be...
